Joshua Sterling

Dr. Joshua Sterling

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2024 in Journal of Urology
Verified
Journal Article
Open access
JSJoshua Sterling
Joshua Sterling
JSJay Simhan
Jay Simhan
BFBrian of Colorado Flynn
Brian of Colorado Flynn
PRPaul Rusilko
Paul Rusilko
WFWagner A. França
Wagner A. França
DNDmitriy Nikolavsky
Dmitriy Nikolavsky
The treatment of urethral stenosis after a combination of prostatectomy and radiation therapy for prostate cancer is understudied. We evaluate the clinical and patient-related outcomes after dorsal onlay buccal mucosal graft urethroplasty (D-BMGU) in men who underwent prostatectomy and radiation therapy. A multi-institutional, retrospective review of men with vesicourethral anastomotic stenosis or bulbomembranous urethral stricture disease after radical prostatectomy and radiation therapy from 8 institutions between 2013 to 2021 was performed. The primary outcomes were stenosis recurrence and development of de novo stress urinary incontinence. Secondary outcomes were surgical complications, changes in voiding, and patient-reported satisfaction. Forty-five men were treated with D-BMGU for stenosis following prostatectomy and radiation. There was a total of 7 recurrences. Median follow-up in patients without recurrence was 21 months (IQR 12-24). There were no incidents of de novo incontinence, 28 patients were incontinent pre- and postoperatively, and of the 6 patients managed with suprapubic catheter preoperatively, 4 were continent after repair. Following repair, men had significant improvement in postvoid residual, uroflow, International Prostate Symptom Score, and International Prostate Symptom Score quality-of-life domain. Overall satisfaction was +2 or better in 86.6% of men on the Global Response Assessment. D-BMGU is a safe, feasible, and effective technique in patients with urethral stenosis after a combination of prostatectomy and radiation therapy. Although our findings suggest this technique may result in lower rates of de novo urinary incontinence compared to conventional urethral transection and excision techniques, head-to-head comparisons are needed.

7 January 2022 in Clinical Genitourinary Cancer
Verified
Journal Article
Closed access
HPHiren V. Patel
Hiren V. Patel
SKSinae Kim
Sinae Kim
ASArnav Srivastava
Arnav Srivastava
BSBrian M. Shinder
Brian M. Shinder
JSJoshua Sterling
Joshua Sterling
ESEric A. Singer
Eric A. Singer

29 March 2023 in BJU International
Verified
Journal Article
Closed access
JSJoshua Sterling
Joshua Sterling
MDMichael Daneshvar
Michael Daneshvar
DNDmitriy Nikolavsky
Dmitriy Nikolavsky

Verified
Journal Article
Open access
PDF file
JSJoshua Sterling
Joshua Sterling
SRSyed Nahiyaan Rahman
Syed Nahiyaan Rahman
AVAjin Varghese
Ajin Varghese
Javier C. AnguloJavier C. Angulo
Javier C. Angulo
DNDmitriy Nikolavsky
Dmitriy Nikolavsky
Radiation therapy (RT) in the management of pelvic cancers remains a clinical challenge to urologists given the sequelae of urethral stricture disease secondary to fibrosis and vascular insults. The objective of this review is to understand the physiology of radiation-induced stricture disease and to educate urologists in clinical practice regarding future prospective options clinicians have to deal with this condition. The management of post-radiation urethral stricture consists of conservative, endoscopic, and primary reconstructive options. Endoscopic approaches remain an option, but with limited long-term success. Despite concerns with graft take, reconstructive options such as urethroplasties in this population with buccal grafts have shown long-term success rates ranging from 70 to 100%. Robotic reconstruction is augmenting previous options with faster recovery times. Radiation-induced stricture disease is challenging with multiple interventions available, but with successful outcomes demonstrated in various cohorts including urethroplasties with buccal grafts and robotic reconstruction.

22 April 2022 in Urology
Verified
Journal Article
Closed access
PDF file
CPConnor Policastro
Connor Policastro
JSJoshua Sterling
Joshua Sterling
BPBaylee Porter
Baylee Porter
DZDaniel J. Zaccarini
Daniel J. Zaccarini
GLGuanqun Li
Guanqun Li
GBG Bratslavksy
G Bratslavksy

Verified
Journal Article
Open access
PDF file
ECEllen M Cahill
Ellen M Cahill
HPHiren V. Patel
Hiren V. Patel
GKGeorge E. Koch
George E. Koch
JSJoshua Sterling
Joshua Sterling
Urethroplasty is a highly effective surgical treatment for urethral stricture disease. While overall complication rates are low, surgical site infections and urinary tract infections (UTIs) represent the most common complications. Due to the prolonged need for catheterization following reconstruction, many urologists place patients on extended antibiotic prophylaxis postoperatively. However, antibiotic stewardship is important given the risks of antibiotic overuse including opportunistic infections and the emergence of multidrug-resistant organisms. There are currently no established guidelines for the management of antibiotics for patients undergoing urethroplasty, specifically with regard to postoperative prophylaxis through the time of foley catheter removal. In this review, we examine the current literature regarding antibiotic prophylaxis and urethroplasty. Research has shown no clear benefit for extended antibiotic prophylaxis in preventing symptomatic urinary tract infections or stricture recurrence. This is congruent with evidence from other urologic procedures requiring indwelling catheters and/or stents including radical prostatectomy, hypospadias repair, and pyeloplasty. Prospective, randomized trials are needed to further understand the impact of antibiotic prophylaxis on both urethroplasty outcomes and its broader impact on recurrent UTIs and microbial resistance.